OPKO acquires next generation dry powder inhaler to treat respiratory disorders
OPKO Health announced an agreement to acquire Inspiro Medical, an Israeli medical device company developing a new platform to deliver small molecule drugs such as corticosteroids and beta agonists or larger molecules to treat respiratory diseases. April 17, 2014